Bulk Peptide Manufacturing · OEM/ODM · Headquartered in China+852 9764 7769 · Tiered wholesale pricing on request

Cartalax 20mg

◆ Published batch recordLot PH-cx20-0202COA 2605150494Reported 05/18/2026 Verified

Average Purity

99.46%

Test Method

HPLC-MS

Identity

Pass

Endotoxin

Pass

Cartalax 20mg lyophilized peptide vial

◆ Product

Cartalax 20mg

View full product details and compound information.

View Cartalax 20mg product details →

◆ 01

Sample Identification

LabIndependent third-party analytical laboratory
Document TypeCertificate of Analysis
COA Number2605150494
Accession Number2605150494
Search CodeOmni2605150494
ClientOmniPept Global
ProductCartalax 20mg
LotPH-cx20-0202
Received Date05/15/2026
Reported Date05/18/2026

◆ 02

Purity & Quality Analysis

Purity (HPLC)

Average Purity99.46%

Identity & Appearance

IdentityPass

◆ 03

Testing Methods & COA

CERTIFICATE OF ANALYSIS

Mass Identification

Cartalax

Analysis Method

HPLC with UV detection coupled with mass spectrometry (LC-MS)

Average Purity Result

99.46%

Third-Party Verification

Third-party testing completed at Independent third-party analytical laboratory, on 05/18/2026 by Not publicly identified.

COA Number2605150494
Reported05/18/2026
Testing sourceIndependent third-party analytical laboratory

Use search code Omni2605150494 in this site's COA Library to locate the matching published record.

◆ 04

Test History for Cartalax 20mg

2 independent lab tests on file for this product.

99.46%Cartalax 20mgLot PH-cx20-0202COA 2605150494 · 05/18/2026Current →
99.189%Cartalax 20mgLot N/ACOA 2512050188 · 12/8/2025View →